As of 2025-07-10, the Intrinsic Value of Rock Creek Pharmaceuticals Inc (RCPIQ) is -0.35 USD. This RCPIQ valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.00 USD, the upside of Rock Creek Pharmaceuticals Inc is -350,270.21%.
Based on its market price of 0.00 USD and our intrinsic valuation, Rock Creek Pharmaceuticals Inc (RCPIQ) is overvalued by 350,270.21%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.35 - -0.35 | -0.35 | -350,270.21% |
| P/E | (0.02) - (0.07) | (0.04) | -42622.3% |
| DDM - Stable | (0.01) - (11.63) | (5.82) | -5819760.9% |
| DDM - Multi | (0.00) - (5.45) | (0.00) | -4944.8% |
| Market Cap (mil) | 0.02 |
| Beta | 9.02 |
| Outstanding shares (mil) | 170.44 |
| Enterprise Value (mil) | 14.93 |
| Market risk premium | 4.60% |
| Cost of Equity | 210.04% |
| Cost of Debt | 5.00% |
| WACC | 3.85% |